Axsome Therapeutics (AXSM) EBITDA (2015 - 2026)
Axsome Therapeutics (AXSM) posted EBITDA of -$46.9 million for Q2 2026, compared with -$34.59 million a year earlier.
Powered by 
Analysis
Axsome Therapeutics (AXSM) EBITDA (2015 - 2026) Analysis & Trends
For the trailing twelve months through Jun 30, 2026, EBITDA at Axsome Therapeutics was -$176.62 million; for FY2025, it came in at -$158.2 million.
- In prior years, Axsome Therapeutics' EBITDA was -$273.14 million in FY2024, -$224.99 million in FY2023, -$175.4 million in FY2022 and -$124.63 million in FY2021.
- Quarterly EBITDA has run from a low of -$96.53 million in Q4 2023 to a high of -$4.68 million in Q1 2023 over five years.
- According to Business Quant data, EBITDA for the three prior quarters was -$61.11 million (Q1 2026), -$24.8 million (Q4 2025) and -$43.82 million (Q3 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBITDA (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,136.97 Bn | 1,105.55 Bn | 19.71 Bn | 12.29 Bn |
| 2 | Johnson & Johnson | 619.72 Bn | 538.25 Bn | 17.26 Bn | 9.10 Bn |
| 3 | AbbVie | 503.40 Bn | 476.52 Bn | 12.70 Bn | 8.33 Bn |
| 4 | Merck | 370.15 Bn | 324.53 Bn | 12.21 Bn | 999.00 Mn |
| 5 | Novartis Ag | 298.64 Bn | 262.63 Bn | 11.24 Bn | - |
| 6 | Astrazeneca | 261.07 Bn | 234.76 Bn | 12.86 Bn | 5.09 Bn |
| 7 | Amgen | 237.00 Bn | 192.40 Bn | 7.24 Bn | 4.63 Bn |
| 8 | Gilead Sciences | 191.24 Bn | 165.43 Bn | 6.22 Bn | -9.70 Bn |
| 9 | Pfizer | 170.31 Bn | 116.96 Bn | 10.94 Bn | 5.89 Bn |
| 10 | Axsome Therapeutics | 8.09 Bn | 6.82 Bn | 204.81 Mn | -46.76 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | -46.76 Mn |
| Mar 31, 2026 | -60.99 Mn |
| Dec 31, 2025 | -24.68 Mn |
| Sep 30, 2025 | -43.70 Mn |
| Jun 30, 2025 | -34.47 Mn |
| Mar 31, 2025 | -54.59 Mn |
| Dec 31, 2024 | -70.17 Mn |
| Sep 30, 2024 | -60.56 Mn |
| Jun 30, 2024 | -76.05 Mn |
| Mar 31, 2024 | -64.94 Mn |
| Dec 31, 2023 | -96.08 Mn |
| Sep 30, 2023 | -59.75 Mn |
| Jun 30, 2023 | -62.46 Mn |
| Mar 31, 2023 | -4.10 Mn |
| Dec 31, 2022 | -57.88 Mn |
| Sep 30, 2022 | -40.28 Mn |
| Jun 30, 2022 | -37.73 Mn |
| Mar 31, 2022 | -38.03 Mn |
| Dec 31, 2021 | -32.35 Mn |
| Sep 30, 2021 | -33.09 Mn |
API Access
Axsome Therapeutics EBITDA API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=ebitda&ticker=AXSM&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "ebitda", "ticker": "AXSM", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=ebitda&ticker=AXSM&period=max&api_key=YOUR_API_KEY");
const data = await res.json();